Evidence map›Paper›PMID 30947262›Full record

Observational studyPloS one2019

Alterations of the MEK/ERK, BMP, and Wnt/β-catenin pathways detected in the blood of individuals with lymphatic malformations.

Taehan Kim, Elidia Tafoya, Malcolm P Chelliah, Ramrada Lekwuttikarn, Jiang Li, Kavita Y Sarin, Joyce Teng

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. The BMP Pathway in Blood Vessel and Lymphatic Vessel Biology.International journal of molecular sciences · 2021
    Review
  9. Recent Progress in Lymphangioma.Frontiers in pediatrics · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Taehan KimDepartment of Dermatology, Stanford University School of Medicine, Stanford, California, United States of America.
Elidia TafoyaDepartment of Dermatology, Stanford University School of Medicine, Stanford, California, United States of America.
Malcolm P ChelliahStanford University School of Medicine, Stanford, California, United States of America.
Ramrada LekwuttikarnDepartment of Dermatology, Stanford University School of Medicine, Stanford, California, United States of America.
Jiang LiDepartment of Dermatology, Stanford University School of Medicine, Stanford, California, United States of America.
Kavita Y SarinDepartment of Dermatology, Stanford University School of Medicine, Stanford, California, United States of America.ORCID 0000-0001-5363-3053
Joyce TengDepartment of Dermatology, Stanford University School of Medicine, Stanford, California, United States of America.
Stanford University · US

Funding

Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Melinda L. Telli · 2007 to 2026
$71.4M
NCI NIH HHS P30 CA124435
6 · The paper itself

Abstract

Lymphatic malformation (LM) is a developmental anomaly of the lymphatic system that may lead to disfigurement, organ dysfunction and recurrent infection. Though several treatment modalities exist, pharmacotherapy is often associated with side effects and recurrence is common following surgical interventions. Moreover, despite the recent discovery of PIK3CA mutations in lymphatic endothelial cells of LM patients, the full spectrum of molecular pathways involved in LM pathogenesis is poorly understood. Here, we performed RNA sequencing on blood samples obtained from ten LM patients and nine healthy subjects and found 421 differentially expressed genes that stratify LM subjects from healthy controls. Using this LM gene signature, we identified novel pathway alterations in LM, such as oxidative phosphorylation, MEK/ERK, bone morphogenetic protein (BMP), and Wnt/β-catenin pathways, in addition to confirming the known alterations in cell cycle and the PI3K/AKT pathway. Furthermore, we performed computational drug repositioning analysis to predict existing therapies (e.g. sirolimus) and novel classes of drugs for LM. These findings deepen our understanding of LM pathogenesis and may facilitate non-invasive diagnosis, pathway analysis and therapeutic development.

Indexed as

TranscriptomeAdolescentBone Morphogenetic ProteinsCase-Control StudiesChildChild, PreschoolFemaleGene Expression ProfilingHealthy VolunteersHumansLymphatic AbnormalitiesMaleMAP Kinase Signaling SystemOxidative PhosphorylationSequence Analysis, RNAWnt Signaling PathwayBone Morphogenetic Proteins

Identifiers

PMID30947262
PMCPMC6448917
OpenAlexW2927503757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.